InvestorsHub Logo

couldbebetter

03/23/20 11:41 AM

#255163 RE: james murphy #255156

Mr. Murphy, If LLY is taking such actions other BP will as well.
I wonder if this will "spoil" ongoing trials such as MDCOs PCSK-9
which is owned by NVS. If the study gets compromised the expected
approval and use of that drug may be significantly delayed. One
hopes that the situation will increase the odds of a deal getting
done for a takeout of AMRN.